A Slow Beat and a Dizzying Feat: COVID-19 Related Bradyarrhythmia

Coronavirus disease (COVID-19) was formerly thought to be a respiratory ailment, however it has since been discovered to have an impact on practically all organ systems. Bradycardia is a recently identified COVID-19 ramification with uncertain prognostic significance. To the best of our knowledge, very few case reports have been reported on marked bradycardia as a complication of Covid-19 infection. Studies have revealed a higher risk of mortality in individuals with underlying cardiovascular disease as well as an increase in the prevalence of arrhythmias, cardiomyopathies, myocarditis, and acute coronary syndromes in infected patients. We report a case of a 72 year old male patient who exhibited persistent bradycardia following COVID-19 infection resulting in significant dizziness as a symptom. Clinicians should be aware of the mechanism by which COVID-19 affects the cardiovascular system and the drug side effects that are used in the treatment strategy for this fatal virus, even if the pathophysiology of bradycardia in COVID-19 may be multifactorial. A thorough review examining bradyarrhythmia and relative bradycardia in COVID-19-infected patients has not yet been published.